
ONWARD Medical secures €40.6M to accelerate Breakthrough Therapies for Spinal Cord Injuries
Eindhoven-based neurotechnology company ONWARD Medical has raised €40.6 million through an accelerated private placement, strengthening its mission to develop therapies that restore movement and independence for people with spinal cord injuries and related disorders.













